Cochrane Abstracts
Haloperidol for agitation in dementia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Haloperidol for Agitation in Dementia." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434926/all/Haloperidol_for_agitation_in_dementia.
Haloperidol for agitation in dementia. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434926/all/Haloperidol_for_agitation_in_dementia. Accessed November 22, 2024.
Haloperidol for agitation in dementia. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434926/all/Haloperidol_for_agitation_in_dementia
Haloperidol for Agitation in Dementia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434926/all/Haloperidol_for_agitation_in_dementia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Haloperidol for agitation in dementia
ID - 434926
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434926/all/Haloperidol_for_agitation_in_dementia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
